Hasil Pencarian - Matthew Gumbleton

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    SHIPi Enhances Autologous and Allogeneic Hematopoietic Stem Cell Transplantation

    SHIPi Enhances Autologous and Allogeneic Hematopoietic Stem Cell Transplantation oleh Sandra Fernandes, Robert Brooks, Matthew Gumbleton, Mi-Young Park, Christopher M. Russo, Kyle T. Howard, John D. Chisholm, William G. Kerr

    Diterbitkan 2015-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE)

    A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the s... oleh Matthew Gumbleton, Stephanie Allan, Hannah Conway, Kenneth Boucher, James Marvin, Josiah Hawks, William Burnett, Matthew Van Brocklin, Jonathan Whisenant, Glynn Gilcrease, Sumati Gupta

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Lichen striatus as an immune-related adverse event following ipilimumab/nivolumab and COVID-19 infection in an adult

    Lichen striatus as an immune-related adverse event following ipilimumab/nivolumab and COVID-19 infection in an adult oleh Courtney M. Kenyon, BS, Brenna G. Kelly, MD, Anneli R. Bowen, MD, Matthew Gumbleton, MD, PhD, Dekker C. Deacon, MD, PhD

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: